Seattle, WA, United States of America

Sheena K Aurora

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 96(Granted Patents)


Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Sheena K Aurora: Innovator in Botulinum Toxin Administration

Introduction: Sheena K Aurora is an accomplished inventor based in Seattle, WA, with a notable contribution to the field of medical innovations. With a total of nine patents to her name, she has made significant strides in the treatment of disorders through her groundbreaking work.

Latest Patents: Among her recent achievements is the development of an injection paradigm for the administration of botulinum toxins. This innovative approach aims to treat various disorders, including migraine headaches. Aurora's method combines a fixed site and fixed dose with an optional variable dosage and injection site based on the patient’s pain. This paradigm is designed to optimize the clinical effectiveness of botulinum toxin administration for patients suffering from chronic migraines, showcasing her dedication to improving patient care.

Career Highlights: Throughout her career, Sheena K Aurora has combined her expertise in medical research with a passion for innovation. As an inventor, she has contributed to advancements that enhance the clinical application of botulinum toxins. Her work has garnered recognition within the scientific community, particularly for its impact on headache treatments.

Collaborations: Aurora collaborates closely with notable colleagues, including Catherine C Turkel and Mitchell F Brin, at Allergan, Inc. Their joint efforts reflect a commitment to excellence in research and development, further enhancing the foundation of her innovative approaches in the medical sector.

Conclusion: Sheena K Aurora stands out as a pioneering inventor whose work has the potential to transform the treatment of migraine headaches and other disorders through the use of botulinum toxins. With her unique approach and valuable collaborations, she continues to push the boundaries of medical innovation, promising a brighter future for patients in need of effective treatment solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…